PDB14 BUDGET IMPACT ANALYSIS OF THE INTRODUCTION OF SAXAGLIPTIN IN THE TREATMENT OF TYPE 2 DIABETES IN ARGENTINA

Autor:	L Jotimliansky, E.C. Aiello, Joaquín Caporale, M. Waschbusch, Juan José Gagliardino, Jorge Federico Elgart
Rok vydání:	2010
Předmět:	medicine.medical_specialty business.industry Health Policy Public Health Environmental and Occupational Health Budget impact Type 2 diabetes Saxagliptin medicine.disease chemistry.chemical_compound Endocrinology chemistry Internal medicine Environmental health Medicine business
Zdroj:	Value in Health. 13:A57
ISSN:	1098-3015
DOI:	10.1016/s1098-3015(10)72261-0
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce15655c58b1c420de269c1981bb1811 https://doi.org/10.1016/s1098-3015(10)72261-0 Zobrazit plný text záznamu Full Text from ScienceDirect Plný text